CClinicalTrials.gg
CompletedNCT07742462Updated Aug 3, 2026

The Effects of Interval Sprint Training on Physical Performance and Competition Anxiety in College Soccer Players

An interventional study of repeated sprint training and Sham in College Soccer Players, sponsored by Xiang Gao. Completed at 1 site in China. Open to male participants aged 18 Years to 24 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-03.

Sponsored by Xiang Gao · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 1 year 8 months after the study started (first participant enrolled Nov 2024, registered Jul 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
27
Allocation
Randomized
Ages
18 Years to 24 Years
Sex
Male
01

Study summary

To investigate the comprehensive effects of structured repeated sprint training (RST) on the multidimensional physical performance and competition-related anxiety of college soccer players.

02

Conditions studied

  • College Soccer Players
03

In context

Lead sponsor

Xiang Gao is the lead sponsor of 5 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 24 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Inclusion criteria

  1. Age 18-24 years;
  2. At least 3 years of systematic soccer training;
  3. No history of severe lower-limb sports injuries within the past 6 months (defined as injuries resulting in ≥4 weeks of training cessation);
  4. No participation in any form of repeated sprinting or high-intensity interval training programs during the 2 months prior to the study.

Exclusion criteria

Exclusion Criteria:

  1. Presence of any cardiovascular, metabolic, or musculoskeletal conditions that may affect testing or training;
  2. Inability to guarantee attendance during the study period (expected number of absences > 2).
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
27 participants (actual)

Study arms

  • Experimental
    Experimental group

    Behavioral: repeated sprint training

  • Sham comparator
    Control Group

    Behavioral: Sham

Interventions

  • Behavioralrepeated sprint training

    In Weeks 1-3, they completed 1 set of 8 × 30-meter straight-line sprints, with a 30-second rest after each sprint; in Weeks 4-6, the workload was increased to 2 sets of 8 × 30-meter sprints, with a 30-second rest between sprints within each set and a 3-minute rest between sets

  • BehavioralSham

    Sham

06

What researchers measure

Primary outcomes

  1. 20-meter straight-line sprint

    Time frame: 6 weeks

07

Study locations

1 site
  • Guangzhou Sport University
    Guangzhou, Guangdong 510000, China
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07742462
Lead sponsor
Xiang Gao
Responsible party
Xiang Gao (Director, Guangzhou Sport University) — Sponsor-investigator
First posted
Aug 3, 2026
Start date
Nov 4, 2024
Primary completion
Dec 13, 2024
Completion
Dec 13, 2024
Last update
Aug 3, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion